Hacker News Board Hacker News, browsed like a classic message board
Live data from Hacker News

Hydroxychloroquine Probably Isn’t the Answer

acsh.org

Post reply on HN
Print view View original

51–60 of 115 posts

Re: Hydroxychloroquine Probably Isn’t the Answer

#51

Post by stewbrew »

hexl wrote: post #27
stri8ed wrote: post #16

Not to diminish the possible successes, but without a randomized control trial, there is no way the success can reliably be attributed to the medications. That's not to say they should stop prescribing it, simply due to lack of formal trials. But the perceived benefits should not be taken at face value, yet.

> but without a randomized control trial, there is no way the success can reliably be attributed to the medications That's non-sense, if everyone that had cancer got cured by a miracle drug, would you still demand a randomized control trial?

Unless you did such a trial, you cannot be sure it actually was the drug that helped. But if everyone gets cured, such a trial should be easy to set up. Unfortunately, things are not that easy in real life. There is no miracle drug.

Re: Hydroxychloroquine Probably Isn’t the Answer

#53

Post by inamberclad »

ucha wrote: post #45

This morning we had: France ex-IHU Marseille/AP-HP: 79160 cases, 7527 dead, mortality rate 9.5% IHU Marseille/AP-HP: 3005 cases, 33 dead, mortality rate 1.1% France doesn't use HCQ consistently yet. Didier Raoult who heads the IHU in Marseille has been using it systematically on all cases, even mild ones for more than 2 weeks. I doubt such a difference in mortality rate could be explained by a difference in number of…

It also doesn't count for confounding factors. Were all the patients of the same health? Did they all have the same supportive equipment? Did they all begin treatment at the same time after symptom onset? These are all questions that need to be addressed, the sooner the better.

Re: Hydroxychloroquine Probably Isn’t the Answer

#54

Post by wolco »

ucha wrote: post #45

This morning we had: France ex-IHU Marseille/AP-HP: 79160 cases, 7527 dead, mortality rate 9.5% IHU Marseille/AP-HP: 3005 cases, 33 dead, mortality rate 1.1% France doesn't use HCQ consistently yet. Didier Raoult who heads the IHU in Marseille has been using it systematically on all cases, even mild ones for more than 2 weeks. I doubt such a difference in mortality rate could be explained by a difference in number of…

Each of the 3005 had proper full care and were closely watched. We don't know about the 79160. The difference in mortality could be a number of factors.

Re: Hydroxychloroquine Probably Isn’t the Answer

#55

Post by Dylan16807 »

h_r wrote: post #32
hexl wrote: post #27

Earlier quoted context omitted.

> but without a randomized control trial, there is no way the success can reliably be attributed to the medications That's non-sense, if everyone that had cancer got cured by a miracle drug, would you still demand a randomized control trial?

It's simply a problem of what is considered to be evidence in the scientific community. If everyone "got cured by a miracle drug", that implies you already have the compelling evidence in hand that the drug, in fact, is a cure. This is an example of begging the question.

It's not begging the question at all! The entire point is that you can have compelling evidence without a randomized controlled trial.

Re: Hydroxychloroquine Probably Isn’t the Answer

#56

Post by pbreit »

ysleepy wrote: post #6

If it would have situation altering effects we would already know. Huge effects would have been seen very early in the wide spread application of it.

Not necessarily. There are still a few variables like when it is offered, what drug combinations, comorbidities, dosage, etc.

Re: Hydroxychloroquine Probably Isn’t the Answer

#57

Post by cma »

ucha wrote: post #45

This morning we had: France ex-IHU Marseille/AP-HP: 79160 cases, 7527 dead, mortality rate 9.5% IHU Marseille/AP-HP: 3005 cases, 33 dead, mortality rate 1.1% France doesn't use HCQ consistently yet. Didier Raoult who heads the IHU in Marseille has been using it systematically on all cases, even mild ones for more than 2 weeks. I doubt such a difference in mortality rate could be explained by a difference in number of…

Does Marseille test more than France? It is expected no one is hitting a 9.5% death rate unless they quit testing almost all but the severe or dead.

Re: Hydroxychloroquine Probably Isn’t the Answer

#58

Post by pbreit »

gonational wrote: post #19

Has anyone noticed that the CDC’s reported deaths by week from ordinary flu and pneumonia have been plummeting while COVID-19 death rise? They are down from the normal 4.5k+ per week during this period to around 2.3k per week and they are falling parabolically as COVID-19 expands. What could cause this?

I only saw one bit of data on this and it was unclear if the data was reliable. Apparently the data from the CDC on this may take awhile to finalize.

Do you have any pointers?

Re: Hydroxychloroquine Probably Isn’t the Answer

#59

Post by js4ever »

logicbombr wrote: post #10

Prevent Senior in Brazil, an health operator with mosts of its patients on risk groups (60+ yo) are using hydroxychloroquine on all its COVID-19 patients with tremendous success. Right now I choose to believe on MD in front line rather then in Health Societies, FDA, WHO and those bureaucrats who let the virus spread all around due to its incompetence

Agreed, also Hydroxychloroquine cost only few cents per pill, its probably too hard to swallow for big labs that want to sell $$$$$ treatment instead ... Poor them ...
Post reply on HN